Emergent BioSolutions is being tracked by MarketBeat, benchmarking its volatility against the S&P 500, while also competing with Viridian Therapeutics.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Emergent BioSolutions is being tracked by MarketBeat, benchmarking its volatility against the S&P 500, while also competing with Viridian Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Emergent BioSolutions
multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA
Nothing else this week.
-
MarketBeat
American personal finance blog
- Canadian companies, including Canadian Natural Resources and Celsius Network, are listed on Canadian exchanges and operate as major transcontinental freight railways.
- TD Cowen boosted the price target for Eos Energy Enterprises, Inc., while MarketBeat provided average rating data and the company filed a transaction disclosure with the SEC.
Related events
- MarketBeat provided analyst recommendations and compared the financial metrics and investment potential of Pioneer Bancorp and Community West Bancshares against the S&P 500.
- MarketBeat reported on the stock performance of Allarity Therapeutics, Inc. on September 1, 2026.
- MarketBeat provided stock performance data and analyst recommendations for Regeneron Pharmaceuticals and IDEAYA Biosciences.
- Rapid Micro Biosystems and Thermo Fisher Scientific are competing in the life sciences/healthcare market, with MarketBeat providing analyst ratings and coverage.
- MarketBeat provided analyst ratings and targets for small-cap healthcare companies Emergent BioSolutions and Entrada Therapeutics.